-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's right to use underlying asset under operating lease.
-
Summary
-
Cytek Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q1 2025.
- Cytek Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2025 was $9.87M, a 0.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)